Clinical Trial Update: Feature Assessment Study for Indications Based Programming

View source ↗

Summary

Boston Scientific's Indications-Based Programming trial (NCT00711893) evaluating an indications-based programming approach for ventricular tachyarrhythmias and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Ventricular Fibrillation
• Ventricular Flutter
• Ventricular Tachycardia

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Ventricular Tachycardia, Ventricular Flutter | Status: COMPLETED